Effect of the Women's health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 1, 2007, Pages 157-160

  Dorval, Michel ^a,b   Vallée, Marie Hélène ^a   Plante, Marie ^b   Chiquette, Jocelyne ^b   Gaudet, Michel ^b   Simard, Jacques ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; HORMONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HETEROZYGOTE DETECTION; HORMONE SUBSTITUTION; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MATERNAL WELFARE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; QUESTIONNAIRE;

EID: 33846626073     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0340     Document Type: Article

References (21)

1. Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Hersh A, Stefanick M, Stafford R. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291:47-53.
3. Majumdar S, Almasi E, Stafford R. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 2004; 292:1983-8.
4. Rouleau I, Chiquette J, Plante M, Simard J, Dorval M. Changes in health-related behaviours following BRCA1/2 genetic testing: the case of hormone replacement therapy. J Obstet Gynaecol Can 2004;26:1059-66.
5. Sade R, Chetrit A, Figer A, et al. Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers. Eur J Cancer 2006;42: 650-5.
6. Avard D, Bridge P, Bucci L, et al. Partening in oncogenetics research-the INHERIT BRCAs experience: opportunities and challenges. Fam Cancer 2006;5:3-13.
7. American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-406.
8. Ziegler A, Blettner M, Kastner C, Chang-Claude J. Identifying influential families using regression diagnostics for generalized estimating equations. Genet Epidemiol 1998;15:341-53.
9. Statistical Analysis System version 9.1. Cary (NC): The SAS Institute; 2005.
10. Blackwood MA, Weber BL. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol 1998;16:1969-77.
11. Canadian Cancer Society. Recommendation about combined hormone replacement therapy. Montreal (Canada): Canadian Cancer Society; 2004.
12. Rebbeck T, Levin A, Eisen A, et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1475-9.
13. Rebbeck T, Lynch H, Neuhausen S, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.
14. Kauff N, Satagopan J, Robson M, et al. Risk-reducing salpingo- oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002; 346:1609-15.
15. Rebbeck T, Friebel T, Wagner T, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2005;23:7804-10.
16. Eisinger F, Bressac B, Castaigne D, et al. Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 2004;91:219-37.
17. McIntosh A, Shaw C, Evans G, et al. Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. London: National Collaborating Centre for Primary Care/University of Sheffield; 2004.
18. Miller SM, Shoda Y, Hurley K. Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 1996;119:70-94.
19. Burak LJ, Meyer M. Using the Health Belief Model to examine and predict college women's cervical cancer screening beliefs and behavior. Health Care Women Int 1997;18:251-62.
20. Rabin C, Pinto B. Cancer-related beliefs and health behavior change among breast cancer survivors and their first-degree relatives. Psychooncology 2006;15:701-12.
21. Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer 2005;4:97-103.